Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Phase 1/2 Unknown
30 enrolled
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
Phase 1/2 Unknown
50 enrolled
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1/2 Unknown
30 enrolled
Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor
Phase 1/2 Unknown
62 enrolled
Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Phase 1/2 Unknown
54 enrolled
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
Phase 1/2 Unknown
50 enrolled
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Phase 1/2 Unknown
37 enrolled
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1/2 Unknown
30 enrolled
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
Phase 1/2 Unknown
36 enrolled
Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
Phase 1/2 Unknown
Biological Therapy in Treating Women With Metastatic Breast Cancer
Phase 1/2 Unknown
60 enrolled
Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
Phase 1/2 Unknown
16 enrolled
Beta Alethine in Treating Patients With Myeloma
Phase 1/2 Unknown
Beta Alethine in Treating Patients With Low-Grade Lymphoma
Phase 1/2 Unknown
NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase 1/2 Unknown
Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
Phase 1/2 Unknown
Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
Phase 1/2 Unknown
64 enrolled
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
Phase 1/2 Unknown
46 enrolled
Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
Phase 1/2 Unknown
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
Phase 1/2 Unknown
Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Unknown
Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 1/2 Unknown
Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
Phase 1/2 Unknown
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
Phase 1/2 Unknown
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
Phase 1/2 Unknown
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm
Phase 1/2 Unknown
Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
Phase 1/2 Unknown
35 enrolled
Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
Phase 1/2 Unknown
Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
Phase 1/2 Unknown
30 enrolled
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma
Phase 1/2 Unknown
84 enrolled
Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
Phase 1/2 Unknown
60 enrolled
Vaccine Therapy in Treating Patients With Stage IV Melanoma
Phase 1/2 Unknown
30 enrolled
Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes
Phase 1/2 Unknown
22 enrolled
Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer
Phase 1/2 Unknown
70 enrolled
Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer
Phase 1/2 Unknown
74 enrolled
Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Phase 1/2 Unknown
24 enrolled
Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
Phase 1/2 Unknown
58 enrolled
Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
Phase 1/2 Unknown
30 enrolled
Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus
Phase 1/2 Unknown
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Phase 1/2 Unknown